CASE REPORTS
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Inguinal hyperhidrosis misdiagnosed as urinary incontinence: treatment with botulinum toxin A.

Hyperhidrosis is a psychosocially embarrassing condition with a treatment history of varied success, including topical application of antiperspirants with aluminum salts (e.g., Drysol), oral anticholinergics, iontophoresis, and endoscopic transthoracic sympathectomy. The use of botulinum toxin type A (Botox) in humans for the treatment of hyperhidrosis didn't emerge until 1996. Botulinum toxin A is a safe and effective treatment for hyperhidrosis, and it has been shown to improve the quality of life in affected patients. The toxin works by inhibiting the release of acetylcholine at the neuromuscular junction, and affecting the postganglionic sympathetic innervation of sweat glands. The authors report a case of inguinal hyperhidrosis treated with botulinum toxin A. Very few cases with similar treatments have been found in the medical literature. More work should be done to find the optimal dose for treating this area, and affected patients should be informed of the potential benefits of botulinum toxin therapy.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app